Recruiting
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
NCT05884320
- Conditions
- Gland, Head and Neck Neoplasms, Mouth Diseases, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States